Page last updated: 2024-08-17

levodopa and Atrophy, Muscle

levodopa has been researched along with Atrophy, Muscle in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19902 (20.00)18.7374
1990's4 (40.00)18.2507
2000's3 (30.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kwak, YT; Yang, Y1
Menkes, DL; Silvers, DS1
Lochner, P; Nardone, R; Tezzon, F1
Amanova, ZN; Badalian, LO; Temin, PA1
Lang, AE1
Bertolasi, L; Costa, B; Fiaschi, A; Zanette, G1
Kurisaki, H; Mizuno, T1
Bressman, SB; Ford, B; Greene, PE; Hyland, K1
Bannister, R; Mackay, AV; Quik, M; Spokes, EG1
Abbott, RJ; D'Costa, DF; Millac, PA; Pye, IF1

Reviews

1 review(s) available for levodopa and Atrophy, Muscle

ArticleYear
Hemiatrophy, juvenile-onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult-onset hemiparkinsonism: the spectrum of hemiparkinsonism-hemiatrophy syndrome.
    Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:4

    Topics: Antiparkinson Agents; Blood Glucose; Carbidopa; Contrast Media; Deoxyglucose; Dihydroxyphenylalanine; Dominance, Cerebral; Drug Combinations; Female; Fluorodeoxyglucose F18; Functional Laterality; Hemiplegia; Humans; Levodopa; Middle Aged; Muscle Hypotonia; Muscular Atrophy; Neurologic Examination; Parkinson Disease, Secondary; Physical Exertion; Substantia Nigra; Tomography, Emission-Computed

1995

Other Studies

9 other study(ies) available for levodopa and Atrophy, Muscle

ArticleYear
Hemiparkinsonism-hemiatrophy syndrome with Alzheimer's disease.
    Geriatrics & gerontology international, 2015, Volume: 15, Issue:1

    Topics: Alzheimer Disease; Antiparkinson Agents; Humans; Levodopa; Male; Middle Aged; Muscular Atrophy; Positron-Emission Tomography; Syndrome

2015
Hemibody mirror movements in hemiparkinsonism-hemiatrophy syndrome.
    Journal of the neurological sciences, 2009, Dec-15, Volume: 287, Issue:1-2

    Topics: Antiparkinson Agents; Arm; Electromyography; Facial Muscles; Functional Laterality; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Muscle Contraction; Muscle, Skeletal; Muscular Atrophy; Parkinsonian Disorders; Peripheral Nervous System Diseases; Syndrome; Treatment Outcome

2009
Hemiparkinson-hemiatrophy syndrome: a transcranial magnetic stimulation study.
    Electromyography and clinical neurophysiology, 2003, Volume: 43, Issue:4

    Topics: Antiparkinson Agents; Diagnosis, Differential; Electric Stimulation; Female; Humans; Levodopa; Male; Middle Aged; Muscular Atrophy; Parkinson Disease; Predictive Value of Tests; Syndrome; Transcranial Magnetic Stimulation

2003
[Value of the test with Nakom for assessing the state of the sympathoadrenal system in patients with different forms of progressive muscular dystrophy].
    Laboratornoe delo, 1984, Issue:11

    Topics: Adolescent; Adult; Carbidopa; Catecholamines; Child; Child, Preschool; Drug Combinations; Humans; Levodopa; Male; Muscular Atrophy; Muscular Dystrophies

1984
Hemiparkinsonism-hemiatrophy syndrome: neuroradiological and neurophysiological findings.
    European neurology, 1994, Volume: 34, Issue:2

    Topics: Adult; Cerebral Infarction; Evoked Potentials, Somatosensory; Functional Laterality; Humans; Levodopa; Magnetic Resonance Imaging; Male; Mesencephalon; Muscular Atrophy; Neurologic Examination; Parkinson Disease, Secondary; Reaction Time; Syndrome

1994
[A case of multiple system atrophy presenting a regular involuntary movement of the neck muscles synchronous with respiration].
    Rinsho shinkeigaku = Clinical neurology, 1993, Volume: 33, Issue:7

    Topics: Amantadine; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Middle Aged; Muscular Atrophy; Neck Muscles; Respiration; Trihexyphenidyl

1993
Parkinsonism, dystonia, and hemiatrophy.
    Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:3

    Topics: Adolescent; Antiparkinson Agents; Carbidopa; Caudate Nucleus; Child; Child, Preschool; Dominance, Cerebral; Drug Therapy, Combination; Dystonia; Humans; Infant; Infant, Newborn; Levodopa; Magnetic Resonance Imaging; Muscular Atrophy; Neurologic Examination; Parkinson Disease; Putamen; Treatment Outcome

2000
Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's disease.
    Journal of the neurological sciences, 1979, Volume: 43, Issue:3

    Topics: Binding Sites; Butyrophenones; Caudate Nucleus; Cerebral Cortex; Frontal Lobe; Humans; Levodopa; Muscular Atrophy; Neuromuscular Diseases; Parkinson Disease; Receptors, Dopamine; Spiperone; Substantia Nigra; Syndrome

1979
The apomorphine test in parkinsonian syndromes.
    Journal of neurology, neurosurgery, and psychiatry, 1991, Volume: 54, Issue:10

    Topics: Aged; Apomorphine; Diagnosis, Differential; Female; Humans; Levodopa; Lewy Bodies; Male; Middle Aged; Muscular Atrophy; Neurologic Examination; Olivopontocerebellar Atrophies; Parkinson Disease; Parkinson Disease, Secondary; Prognosis; Supranuclear Palsy, Progressive

1991